Citation only
via OpenAlex
Promoting NAD+ Metabolism: A new Target for Treating Degenerative Disease
Ross Grant, Jade Berg, Nady Braidy
Journal of the Australasian College of Nutritional and Environmental Medicine · 2016
Abstract
NAD+ is found in every cell of the body and is essential for life. It serves as a cofactor for dehydrogenase, reductase and hydroxylase enzymes where it facilitates electron transfer in major metabolic pathways such as glycolysis, the triacarboxylic acid (TCA) cycle, fatty acid synthesis and steroid hormone synthesis, enabling the conversion of the food we eat into the energy and chemical products the body needs. More recently it has been found that NAD+ is also required as a substrate by enzymes that regulate the expression of genes involved in cell viability and aging and in repair of damaged DNA. Through these reactions, NAD+ influences a variety of cell processes involved in cell health, including improving mitochondrial efficiency, enhancing cell viability, down-regulating inflammation, increasing the antioxidant capacity of cells and tissues, and activating the 'longevity' enzyme SIRT1. An increasing body of evidence indicates that enhancing NAD+ availability in the brain has the potential to moderate elements of the neurodegenerative disease processes associated with oxidative stress and aging, including Alzheimer's disease. However there are difficulties associated with raising NAD+ levels using the classical pathway and vitamin B3 precursors nicotinic acid and nicotinamide. The recent discovery of two alternative naturally occurring B3 vitamins; nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) may resolve these problems. NR in particular has shown good efficacy in its ability to raise NAD+ levels under a variety of conditions. Directly boosting [NAD+] may present a new and exciting approach to preventing the natural decline in cellular energy and function as we age, particularly in the brain.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- Canonical
- link ↗
- Fetched
- 2026-10-09 MST
Cite this
APA
Grant, R., Berg, J., & Braidy, N. (2016). Promoting NAD+ Metabolism: A new Target for Treating Degenerative Disease. <em>Journal of the Australasian College of Nutritional and Environmental Medicine</em>. https://openalex.org/W2922530442
Vancouver
Grant R, Berg J, Braidy N. Promoting NAD+ Metabolism: A new Target for Treating Degenerative Disease. Journal of the Australasian College of Nutritional and Environmental Medicine. 2016.
BibTeX
@article{ross2016Promot,
title = {Promoting NAD+ Metabolism: A new Target for Treating Degenerative Disease},
author = {Ross Grant and Jade Berg and Nady Braidy},
journal = {Journal of the Australasian College of Nutritional and Environmental Medicine},
year = {2016},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Trends in Cell Biology 2023
Open access · CC-BY
The autophagy–NAD axis in longevity and disease
Journal of Biomedical Science 2019
Open access · CC-BY
Implications of altered NAD metabolism in metabolic disorders
npj Metabolic Health and Disease 2025
Open access · CC-BY
The role of NAD+ metabolism and its modulation of mitochondria in aging and disease
Frontiers in sports and active living 2026
Open access · OA
The role of exercise in modulating NAD+ metabolic enzymes: mechanisms and health benefits.
The Research Repository @ WVU (West Virginia University) 2026
Preprint · OA
GCN5L1-mediated lysine acetylation regulates mitochondrial dysfunction in the aged heart
Journal of Neuroscience Research 2011
Open access · OA